Creative Biolabs-Immuno-oncology

Anti-LAG3 (clone Ab9Q) SynExpress E1-Cy2-I17-P Modified CD8+ T cells (CAT#: ITS-1224-CR1989)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target LAG3 (clone Ab9Q). We employs the pCDNA (EF1α-Cy2-IL-17-PstI) vector components and the SynExpress system of the Single base pair Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
Humanized
Target
LAG3
Clone
Ab9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
EF1α
Effector Gene
IL-17
Insertion Sites
PstI
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
pCDNA
Transformation Accuracy
0.91
Cell Culture
3D Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.